688198 佰仁医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.07015.00811.95910.0359.099
总资产报酬率 ROA (%)2.57212.67710.6129.1918.605
投入资产回报率 ROIC (%)2.80314.04911.6469.8859.037

边际利润分析
销售毛利率 (%)88.16689.18288.33989.84589.375
营业利润率 (%)34.47434.18430.52932.59836.393
息税前利润/营业总收入 (%)35.09733.20528.68232.36235.629
净利润/营业总收入 (%)30.21728.97426.33029.51931.980

收益指标分析
经营活动净收益/利润总额(%)95.14990.04592.60083.47279.291
价值变动净收益/利润总额(%)3.6234.2097.13214.89321.014
营业外收支净额/利润总额(%)0.074-2.844-1.614-0.668-1.209

偿债能力分析
流动比率 (X)5.3983.9755.1708.42911.451
速动比率 (X)4.9133.6734.7087.99610.953
资产负债率 (%)14.87119.08912.59910.4346.822
带息债务/全部投入资本 (%)2.5663.829-2.206-2.432-0.943
股东权益/带息债务 (%)3,588.3642,365.001-4,401.002-4,017.473-10,542.428
股东权益/负债合计 (%)577.369428.280694.817862.7531,368.390
利息保障倍数 (X)58.718-996.195-21.058-1,704.972-108.218

营运能力分析
应收账款周转天数 (天)108.22982.32073.54068.70559.991
存货周转天数 (天)383.841325.617269.552317.476306.770